Related Experiment Video
Updated: Jun 28, 2026

Measuring Phagocytosis of Aspergillus fumigatus Conidia by Human Leukocytes using Flow Cytometry
Published on: December 7, 2019
Aspergillus conidia activate the complement by the mannan-binding lectin C2 bypass mechanism
Chantal Dumestre-Pérard1, Bertrand Lamy, Delphine Aldebert
1Laboratoire Adaptation et Pathogénie des Micro-organismes, Université Joseph Fourier, Grenoble 1, BP 170, Grenoble, France. Chantal.Dumestre@ujf-grenoble.fr
Abstract:
Innate immunity is the major host defense against invasive aspergillosis. To determine whether the collectin mannan-binding lectin (MBL) is involved in the initial protective immunity through complement activation against opportunistic fungal infections caused by Aspergillus, we performed in vitro studies on 29 different strains of Aspergillus conidia from five different species. Incubation of Aspergillus conidia in human normal serum leads to activation of the alternative pathway, whereas neither the classical nor the lectin pathways through C4 and C2 cleavage are activated. Complement response to conidia was investigated using a MBL-deficient serum and reconstitution experiments were conducted with MBL/MASPs complexes. We found that MBL can directly support C3 activation by a C2 bypass mechanism. Finally, a stronger activation of the alternative pathway was observed for the clinical strains isolated from patients with invasive aspergillosis, compared with the environmental strains.
Insights
Mannan-binding lectin (MBL) directly supports complement C3 activation via a C2 bypass mechanism, enhancing innate immunity against Aspergillus fungal infections. This finding is crucial for understanding host defense in invasive aspergillosis.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Innate immunity is critical for defense against invasive aspergillosis.
- Mannan-binding lectin (MBL) is a key component of the innate immune system.
- The role of MBL in complement activation against Aspergillus remains to be fully elucidated.
Purpose of the Study:
- To investigate the role of MBL in complement activation against Aspergillus conidia.
- To determine if MBL can initiate complement pathways against fungal infections.
- To compare complement activation by clinical and environmental Aspergillus strains.
Main Methods:
- In vitro studies using 29 Aspergillus conidia strains from five species.
- Incubation with human normal serum and MBL-deficient serum.
- Reconstitution experiments with MBL/MASPs complexes.
- Analysis of complement activation pathways (classical, lectin, alternative).
Main Results:
- Aspergillus conidia activated the alternative complement pathway but not classical or lectin pathways.
- MBL directly supports C3 activation through a C2 bypass mechanism.
- Clinical Aspergillus strains showed stronger alternative pathway activation than environmental strains.
Conclusions:
- MBL plays a direct role in complement activation against Aspergillus via a C2 bypass mechanism.
- This MBL-mediated complement activation contributes to innate immunity against invasive aspergillosis.
- Clinical Aspergillus isolates exhibit enhanced complement activation, suggesting potential virulence factors.
Related Concept Videos
Complement System
Cryptococcal Meningitis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Antifungal Agents
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

